Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Godzenko

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Vestnik Oftalmologii|July 8, 2022
[Genetically engineered biological agents in the treatment of uveitis in patients with ankylosing spondylitis (clinical observations)]I Yu Razumova, A A Godzenko
Vestnik Oftalmologii|December 1, 2018
[Application of TNF-alpha inhibitors in treatment of uveitis associated with ankylosing spondylitis]I Yu Razumova, A A Godzenko
Vestnik Oftalmologii|November 2, 2021
[Behçet's disease and uveitis]I Yu Razumova, A A Godzenko
Vestnik Oftalmologii|October 21, 2020
[Nonsteroidal anti-inflammatory drugs in the treatment of anterior uveitis associated with spondyloarthritis]I Yu Razumova, A A Godzenko
Vestnik Oftalmologii|October 15, 2009
[HLA-B27-associated uveitis]I Iu Razumova, A A Godzenko
Vestnik Oftalmologii|December 27, 2022
[New possibilities in therapy of ocular inflammation in rheumatic diseases]I Yu Razumova, A A Godzenko
Vestnik Oftalmologii|November 7, 2019
[Features of the course of anterior uveitis associated with HLA-B27 antigen]I Yu Razumova, A A Godzenko, I A Guseva
Vestnik Oftalmologii|July 2, 2009
[Diagnosis and treatment of HLA-B27-associated uveitis]I Iu Razumova, O K Vorob'eva, A A Godzenko
Vestnik Oftalmologii|November 23, 2017
[Uveitis-associated HLA class 1 histocompatibility antigens]I Yu Razumova, A A Godzenko, I A Guseva, et al.
Vestnik Oftalmologii|September 8, 2016
[Uveitis in spondyloarthritis patients and its association with HLA-B27 histocompatibility antigen: prospective study]I Yu Razumova, A A Godzenko, O K Vorob'eva, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Vestnik Oftalmologii|July 8, 2022
[Genetically engineered biological agents in the treatment of uveitis in patients with ankylosing spondylitis (clinical observations)]I Yu Razumova, A A Godzenko
Vestnik Oftalmologii|December 1, 2018
[Application of TNF-alpha inhibitors in treatment of uveitis associated with ankylosing spondylitis]I Yu Razumova, A A Godzenko
Vestnik Oftalmologii|November 2, 2021
[Behçet's disease and uveitis]I Yu Razumova, A A Godzenko
Vestnik Oftalmologii|October 21, 2020
[Nonsteroidal anti-inflammatory drugs in the treatment of anterior uveitis associated with spondyloarthritis]I Yu Razumova, A A Godzenko
Vestnik Oftalmologii|October 15, 2009
[HLA-B27-associated uveitis]I Iu Razumova, A A Godzenko
Vestnik Oftalmologii|December 27, 2022
[New possibilities in therapy of ocular inflammation in rheumatic diseases]I Yu Razumova, A A Godzenko
Vestnik Oftalmologii|November 7, 2019
[Features of the course of anterior uveitis associated with HLA-B27 antigen]I Yu Razumova, A A Godzenko, I A Guseva
Vestnik Oftalmologii|July 2, 2009
[Diagnosis and treatment of HLA-B27-associated uveitis]I Iu Razumova, O K Vorob'eva, A A Godzenko
Vestnik Oftalmologii|November 23, 2017
[Uveitis-associated HLA class 1 histocompatibility antigens]I Yu Razumova, A A Godzenko, I A Guseva, et al.
Vestnik Oftalmologii|September 8, 2016
[Uveitis in spondyloarthritis patients and its association with HLA-B27 histocompatibility antigen: prospective study]I Yu Razumova, A A Godzenko, O K Vorob'eva, et al.
Pageof 2